Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631 (Leukemia, (2021), 35, 5, (1279-1290), 10.1038/s41375-021-01177-6)

Academic Article


  • Figure 3 of the original article was an incorrect version. The correct figure is: The original article has been updated. (Figure presented.).
  • Published In

  • Leukemia  Journal
  • Digital Object Identifier (doi)

    Author List

  • Brown PA; Kairalla JA; Hilden JM; Dreyer ZAE; Carroll AJ; Heerema NA; Wang C; Devidas M; Gore L; Salzer WL
  • Start Page

  • 1527
  • Volume

  • 35
  • Issue

  • 5